CVG Falling Apart?

The VAD market is destroying CVG, now forecasting a serious revenue miss. Furloughs, possible RIF's, hiring freeze and spending constraints. Where does it end? No wonder analysts were pushing back on Omar at the JP Morgan meeting last week.

Post A Reply

Report this entire thread

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a thread a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the thread has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.

Imagine selling a pacemaker that doesn't pace because of a software issue.

When will the software update be ready so the issue is corrected? Maybe it's because I'm relatively new in my position but I've experienced a lot more recalls and issues with Medtronic than the company I came from.

post

Another Class I recall....

A subset of Medtronic dual chamber pacemakers distributed worldwide between 10 March 2017 and 7 January 2019 under the brand names Adapta, Versa, and Sensia when programmed to a dual chamber mode with atrial-sensing, may experience a circuit error that affects device functionality

Imagine selling a pacemaker that doesn't pace because of a software issue.

post

483 warnings letters and pacemaker recalls are the envy of CVG.

Q4 RIF coming in hot!

Another Class I recall....

A subset of Medtronic dual chamber pacemakers distributed worldwide between 10 March 2017 and 7 January 2019 under the brand names Adapta, Versa, and Sensia when programmed to a dual chamber mode with atrial-sensing, may experience a circuit error that affects device functionality

post

Fantastic how we try to be on the forefront of technology with iPhones syncing with our pacers but then recall 157,000 dual chambers because they lose the ability to pace. This goes back to the company trying to cut costs but be on the leading edge. Hint: it doesn't work that way.

483 warnings letters and pacemaker recalls are the envy of CVG.

Q4 RIF coming in hot!

post

I agree there are problems in CVG but you're still talking about a $11 billion division which drives 1/3 of the company's total revenue. Heartware was a miss but bring down division though?

Will the EPIX Therapeutics buyout help at all?

post

There's literally been no discussion about HeartWare in earnings calls or at JPM. The company thinks they can put their head in the sand and the street will forget about it. Wrong.

I agree there are problems in CVG but you're still talking about a $11 billion division which drives 1/3 of the company's total revenue. Heartware was a miss but bring down division though?

post

Fantastic how we try to be on the forefront of technology with iPhones syncing with our pacers but then recall 157,000 dual chambers because they lose the ability to pace. This goes back to the company trying to cut costs but be on the leading edge. Hint: it doesn't work that way.

post

There's literally been no discussion about HeartWare in earnings calls or at JPM. The company thinks they can put their head in the sand and the street will forget about it. Wrong.

With Resolute Onyx being the saving grace of the entire division.

post

From the recalls to class actions suits, HeartWare has been a complete disaster.

There's literally been no discussion about HeartWare in earnings calls or at JPM. The company thinks they can put their head in the sand and the street will forget about it. Wrong.

post

From the recalls to class actions suits, HeartWare has been a complete disaster.

post

Loading...


Report this post

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a post a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the post has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.